TransformativeMed Closes $5.8 Series A to Redefine How Clinicians Use the EHR to Communicate and Collaborate

SEATTLE–(BUSINESS WIRE)–lt;a href=”https://twitter.com/hashtag/CORES?src=hash” target=”_blank”gt;#CORESlt;/agt;–TransformativeMed,
the leader in redefining how clinicians communicate and collaborate
using EHR-embedded workflows, today announced that it has closed a $5.8M
Series A financing round led by the Alliance
of Angels
. The funds will be used to accelerate Sales and Marketing
efforts with an aggressive nationwide expansion of the CORES Value Suite
solution. Today TransformativeMed solutions are used by tens of
thousands of clinicians in more than 130 hospitals and health systems to
optimize EHR usability, making patient care more productive and
enjoyable.

TransformativeMed solutions target the clinical communication and
collaboration (CC&C) market. This burgeoning space was narrowly defined
by texting and messaging solutions that require interfaces to connect to
the EHR. TransformativeMed is dramatically expanding the definition of
clinical communication and collaboration with this approach:

  • Out-of-the-box clinician-designed EHR workflows configured by clinical
    specialty and for complex conditions like diabetes. The workflows
    surface relevant EHR data as clinicians work, increasing EHR usability
    and satisfaction by minimizing the frustration of hunting for patient
    data.
  • Smart messaging and texting solutions powered by machine-learning and
    integrated directly into the workflows, create a completely turn-key,
    100% interface-free clinical communication and collaboration solution.
  • Interface-free, EHR-embedded solutions delivered as a SaaS model to
    reduce IT burden and ensure rapid, turnkey implementations.

Clinicians relate to the TransformativeMed story. Co-founder Dr. Erik
Van Eaton was frustrated by the technical barriers the EHR imposed on
delivering efficient patient care. Together he and co-founder David
Stone, a technologist, an inventor of Cerner MPages did something about
it. They redefined how clinicians use the EHR.

TransformativeMed
President and CEO Doug Cusick
stated, “TransformativeMed
built its business through clinical word-of-mouth. This intimate
clinical connection has provided deep insight into what the market
needs, the runway to learn how to deliver a truly turnkey solution to
IT, and most importantly—market proof that our EHR-optimization approach
works.” Cusick added, “We are thrilled with the confidence that our
investors have in our solution and team and are prepared to jumpstart
TransformativeMed’s growth as we redefine the Clinical Communication and
Collaboration market with CORES.”

About TransformativeMed

Founded in 2011, privately-held TransformativeMed is the first to
re-engineer Electronic Health Record (EHR) workflows with directly
embedded, clinician-friendly solutions. The CORE Value Suite curates
EHR-based patient information and presents it in the unique way each
specialty requires. CORES is bi-directionally integrated with
smartphones to ensure clinicians can enter and receive critical alerts,
notifications and messages while they work. This transforms how the EHR
is used. Workflows are streamlined, team communication and collaboration
is accelerated, and the frustrations of mining the EHR for critical
information is removed. Tens of thousands of clinicians across more than
130 hospitals are using CORES to enhance EHR value, including Dignity
Health, Baptist Health, and Medstar and others. Learn more at TransformativeMed.com.

Contacts

Cheryl Isen, for TransformativeMed
Cheryl@IsenandCo.com
or (425) 233-9032

Staff

Recent Posts

HeartBeam Reports Fourth Quarter and Full Year 2023 Financial Results

First Patients Enrolled in Pivotal Study Evaluating AIMIGo™ System for Synthesizing a 12-Lead ECG Ongoing…

15 mins ago

Delivra Health Brands Announces Adoption of a New Fixed Share Option Plan

Vancouver, British Columbia--(Newsfile Corp. - March 20, 2024) - Delivra Health Brands Inc. (TSXV: DHB)…

16 mins ago

Avinger Reports Fourth Quarter and Full Year 2023 Results

New Strategic Partnership Provides Funding to Support U.S. Growth Initiatives and Coronary Product Development, Opens…

16 mins ago

Music’s Healing Influence on Our Physiology

Pioneering the Path of Sound Therapy with Biofield TuningBURLINGTON, VERMONT / ACCESSWIRE / March 20,…

3 hours ago

NLS Pharmaceutics Announces $1.75 Million Registered Direct Offering

ZURICH, SWITZERLAND / ACCESSWIRE / March 20, 2024 / NLS Pharmaceutics Ltd. (Nasdaq:NLSP)(Nasdaq:NLSPW) ("NLS" or…

3 hours ago

Mending Kids’ Imagine Gala Triumphs, Elevating Children’s Surgical Care Initiatives

LOS ANGELES, CA / ACCESSWIRE / March 20, 2024 / The Skirball Cultural Center was…

3 hours ago